These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1101772)

  • 21. Characterization of antibodies following human renal homograft rejection.
    Rolley RT; Williams GM; Lerner RA; Hanscom G; Hume DM
    Transplant Proc; 1969 Mar; 1(1):275-8. PubMed ID: 4944226
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW; Skurzak HM; Klein E; Wigzell H
    J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract]   [Full Text] [Related]  

  • 24. The dynamic state of the lymphocyte membrane. Factors affecting the distribution and turnover of surface immunoglobulins.
    Loor F; Forni L; Pernis B
    Eur J Immunol; 1972 Jun; 2(3):203-12. PubMed ID: 4569167
    [No Abstract]   [Full Text] [Related]  

  • 25. Specific fractionation of immunocompetent cells. Application in the analysis of effector cells involved in cell mediated lysis.
    Wigzell H; Häyry P
    Curr Top Microbiol Immunol; 1974; 67():1-42. PubMed ID: 4281381
    [No Abstract]   [Full Text] [Related]  

  • 26. Surface immunoglobulins on human lymphoid cells.
    Preud'homme JL; Seligmann M
    Prog Clin Immunol; 1974; 2():121-74. PubMed ID: 4217909
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of in vitro immune responses by antisera to H-2 or Ir gene products.
    Tyan ML
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):313-7. PubMed ID: 1082141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional properties of anti-B-cell antigen alloantisera.
    Ferrone S; Pellegrino MA; van Rood JJ; van Leeuwen A
    Transplant Proc; 1977 Mar; 9(1):675-8. PubMed ID: 141136
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers.
    Pattengale PK; Smith RW; Perlin E
    N Engl J Med; 1974 Nov; 291(22):1145-8. PubMed ID: 4138509
    [No Abstract]   [Full Text] [Related]  

  • 32. A study of the transplantation antigens on chondrocytes from articular cartilage.
    Elves MW
    J Bone Joint Surg Br; 1974 Feb; 56(1):178-85. PubMed ID: 4818848
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant and transforming activity of Rous sarcoma virus (RSV). 3. Detection of tumor-specific transplantation and membrane antigens in mouse cell lines transformed in vitro by RSV.
    Kryukova IN; Babkova OV; Obukh IB
    J Natl Cancer Inst; 1971 Oct; 47(4):819-27. PubMed ID: 4328951
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymphocyte receptors for antigen.
    Marchalonis JJ
    J Med; 1974; 5(6):329-67. PubMed ID: 4153398
    [No Abstract]   [Full Text] [Related]  

  • 35. The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias.
    Fu SM; Winchester RJ; Kunkel HG
    J Exp Med; 1975 Nov; 142(5):1334-8. PubMed ID: 1104744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective activation of T lymphocytes. Its possible application in the immunomanipulation of tumours.
    Miller JF
    Biomedicine; 1973 Mar; 18(2):81-5. PubMed ID: 4199988
    [No Abstract]   [Full Text] [Related]  

  • 37. [Different cytotoxic reactivity of anti-HLA A or B sera against sub-population of human lymphocytes prepared with different methods].
    Richiardi P; Crepaldi T; Curtoni ES
    G Batteriol Virol Immunol; 1980; 73(7-12):180-9. PubMed ID: 6975729
    [No Abstract]   [Full Text] [Related]  

  • 38. Humoral factors in specific unresponsiveness to transplantation antigens.
    Brent L; Kilshaw PJ
    Transplant Proc; 1976 Jun; 8(2):209-15. PubMed ID: 779181
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
    Hornung MO; Layne E; McDonald JC
    J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
    [No Abstract]   [Full Text] [Related]  

  • 40. Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines.
    The TH; Huiges HA; Schraffordt Koops H; Lamberts HB; Nieweg HO
    Ann N Y Acad Sci; 1975 Jun; 254():528-40. PubMed ID: 1101782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.